Hi stardestr0yer, been a tough road for this one. They only received FDA approval mid last year so realistically were only then able to start a commercial rollout and then hit by Covid. They have some excellent staff who have done it all with Resmed. They have signed a heap of contracts but the revenue does not seem to translate onto the 4c and the cashburn is big.
IMO the OVN presentations cannot be trusted and are well crafted BS in order to raise capital .
If they do happen to gain commercial traction then this company is a winner but at this stage I only hold options which I envisage will never be in a position to be exercised. This is a capital hungry company.
- Forums
- ASX - By Stock
- OVN
- Ann: Quarterly Business Review & Appendix 4C
Ann: Quarterly Business Review & Appendix 4C, page-18
Featured News
Add OVN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online